pain

Lab manager Rachel Nargi prepares a B-cell culture during the recent “sprint” to develop an antibody-based treatment for Zika virus infection.

Study identifies antibodies that block alphaviruses

Researchers at Vanderbilt University Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global health concern.

Acupressure studied to treat neonatal opioid withdrawal

Researchers from Vanderbilt University Medical Center recently completed a study to create a standardized protocol for using acupressure to treat newborns with opioid withdrawal syndrome.

Study finds aerobic exercise spurs endorphins, relieves low back pain

Six weeks of aerobic exercise can lead to sustained increases in endogenous opioid function and significant relief for chronic low back pain, according to a randomized controlled trial by Vanderbilt University Medical Center’s Stephen Bruehl, PhD, and colleagues, reported in Pain.

New tools to study bioactive lipids

Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction.

Loss of ‘Jedi’ alters neuron activity

This is not the Jedi you’re thinking of. This Jedi is a receptor that helps clear away dead neurons during development, and its loss changes the activity of dorsal root ganglia neurons, which could have implications for treating chronic pain.

An initiative at VUMC is helping patients recover more quickly from major surgery, leave the hospital earlier and have fewer side effects from their pain management.

VUAH applies new approach for patient recovery after surgery

An initiative at VUMC is helping patients recover more quickly from major surgery, leave the hospital earlier and have fewer side effects from their pain management.

1 2 3 4 5